title: Long-term performance of beta-propiolactone-treated nonviable homograft for aortic valve replacement and right ventricular outflow tract reconstruction.
abstract: The long-term performance of beta-propiolactone-treated homografts was clearly different between operative survivors of aortic valve replacement (n = 27) and those of right ventricular outflow tract reconstruction (n = 11). The reoperation-free survival rate at 20 years was 14.8 +/- 6.8 (standard error)% in the former and 77.8 +/- 13.9% in the latter. Even a nonviable aortic homograft can be favorably accepted as a material for right ventricular outflow tract reconstruction in contrast to the aortic position.
authors.affiliation: First Department of Surgery, Osaka University Medical School, Japan.
authors.forename: O
authors.initials: O
authors.lastname: Matsuki
authors.forename: K
authors.initials: K
authors.lastname: Kadoba
authors.forename: S
authors.initials: S
authors.lastname: Nakata
authors.forename: R
authors.initials: R
authors.lastname: Shirakura
authors.forename: S
authors.initials: S
authors.lastname: Nakano
authors.forename: H
authors.initials: H
authors.lastname: Matsuda
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
mesh_terms: D000328:Adult; D001021:Aortic Valve / Q000637:transplantation*; D005260:Female; D006085:Graft Survival; D006349:Heart Valve Diseases / Q000401:mortality / Q000601:surgery; D006801:Humans; D008297:Male; D011420:Propiolactone; D012086:Reoperation; D015996:Survival Rate; D013771:Tetralogy of Fallot / Q000401:mortality / Q000601:surgery; D013997:Time Factors; D014694:Ventricular Outflow Obstruction / Q000401:mortality / Q000601:surgery*
chemical_list: D011420:Propiolactone